Kaveri (Dry Extract Of Ginkgo Biloba Leaves (35-67:1), Extraction Solvent: Acetone 60% ( M / M))

The extract provides flavonoids and terpenoids that act as antioxidants, protect blood vessels, improve microcirculation, and inhibit platelet‑activating factor. These actions together help maintain neuronal health and enhance blood flow to the brain and extremities, which may translate into better cognitive performance and reduced claudication symptoms.

The appropriate dose of Kaveri is determined by the prescribing health professional based on the individual’s age, health status, and therapeutic goal. Over‑the‑counter products typically recommend a daily amount, but exact dosing should follow the prescriber’s instructions or the product label.

Safety data for Ginkgo biloba extract in pregnancy and lactation are limited. Because of potential effects on platelet function, it is generally advised that pregnant or nursing women avoid using Kaveri unless a health‑care provider explicitly recommends it after weighing the risks and benefits.

To place an order, submit an enquiry on the Kaveri product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Kaveri’s Ginkgo biloba extract differs from other herbal options such as Bacopa monnieri or prescription agents like donepezil. Ginkgo primarily improves microcirculation and has antioxidant properties, whereas Bacopa focuses on neurotransmitter modulation. Prescription cholinesterase inhibitors act directly on acetylcholine metabolism and have a stronger evidence base but also a higher side‑effect profile.

Kaveri should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in its original packaging until use to maintain product stability.

Kaveri is taken orally, usually in capsule or tablet form, with water. It can be taken with or without food, but following the prescriber’s guidance on timing and any food‑related considerations helps ensure consistent absorption.

The most serious risks involve bleeding complications, especially in individuals on anticoagulant or antiplatelet therapy, and rare severe allergic reactions such as anaphylaxis. Patients should promptly report unusual bruising, prolonged bleeding, or signs of a severe allergic response to a health professional.

Kaveri should be avoided by people with known hypersensitivity to Ginkgo biloba, those taking anticoagulants or antiplatelet drugs without medical supervision, individuals with bleeding disorders, and pregnant or nursing women unless advised otherwise by a qualified health‑care provider.